Ihr Broker

  • DAX 0,70
  • EUR/USD 0,50
  • GOLD 0,30

Nur Spreads

Keine Kommission

Jetzt registrieren

CFDs sind komplexe Instrumente und umfassen aufgrund der Hebelfinanzierung ein hohes Risiko, schnell Geld zu verlieren.

DiaMonTech GmbH, corporate

DiaMonTech GmbH,

07.10.2019 - 09:04:13

DiaMonTech selected as one of Europe's best deep tech scaleups at the EIT Digital Challenge 2019

DiaMonTech selected as one of Europe's best deep tech scaleups at the EIT Digital Challenge 2019  

Berlin, 7 October 2019 - DiaMonTech GmbH, a young and innovative medical technology company has been nominated by EIT Digital, a leading European player in innovation and entrepreneurial education, as a finalist in its pan-European competition EIT Digital Challenge 2019. The competition focuses on startups in growth stage, so called scaleups, with deep tech products that leverage sophisticated, hard-to-reproduce technologies fueling the digital transformation. "After winning the 'Start me up!' founder prize by BILANZ magazine in 2017, this is already the second renowned competition in which we have reached the final. In a field of nearly 300 participating start-ups, this is already a great distinction that gives us further impetus. With our ground-breaking method for non-invasive blood glucose monitoring, we are developing a product that many people have been waiting for," says Thorsten Lubinski, co-founder and CEO of DiaMonTech GmbH. The participating companies from 12 European countries applied in five categories, strategically chosen with respect to major digital trends and European leadership potential: Digital Tech, Digital Industry, Digital Cities, Digital Finance and Digital Wellbeing. The finalists present their technology to an international expert jury of corporates and investors at the final event in Brussels on 6 November 2019.About DiaMonTech DiaMonTech GmbH is a medical technology company that specializes in the development, design and sale of products for medical diagnostics. The patented photothermal diagnostic technology based on infrared lasers enables the precise measurement of relevant blood parameters. The first application is the non-invasive blood glucose measurement, which enables an accurate and fast measurement without pain. More information about DiaMonTech can be found at www.diamontech.de.Press contact Alexander Neblung Kirchhoff Consult AG Phone +49 40 60 91 86 70 E-mail diamontech@kirchhoff.de

07.10.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de

885783  07.10.2019 

@ dgap.de